Aurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also developing weight loss drugs. Future growth will come from more product launches and a recent acquisition. Backward integration projects are also boosting profitability. The company expects strong earnings growth.
Can Nifty, Sensex extend gains after rallying up to 2% last week? 4 factors to watch on Monday
Indian benchmark indices Sensex and Nifty ended the week higher, gaining up to 0.5%, even as broader markets declined amid rising crude oil prices above